Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.
about
Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.Ovarian Cancer Incidence Corrected for Oophorectomy.Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer.Small fallopian tube carcinoma with extensive upper abdominal dissemination: a case report.Estrogen controls the survival of BRCA1-deficient cells via a PI3K-NRF2-regulated pathway.Probability of fallopian tube and ovarian detection with transvaginal ultrasonography in normal women.Best practices of ASRM and ESHRE: a journey through reproductive medicine.Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers.Should risk-reducing surgery in women from hereditary breast ovarian cancer families be confined to removal of the fallopian tubes with ovarian conservation?Improving mutation notification when new genetic information is identified in research: a trial of two strategies in familial breast cancer.Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers."Best practices in risk reducing bilateral salpingo-oophorectomy: the influence of surgical specialty".Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?
P2860
Q30370475-DAC4E8DE-FE72-48F2-AF7F-ED5AC95F05E3Q33850454-778D53AD-78E2-4742-B06A-36A7A6F5F71AQ34625221-5F1ACEFE-23FB-4EA5-B219-46C5D66B4CEBQ35219159-0AA49CDF-1D99-43B3-B564-7FA7C810B090Q37329307-43CB4233-1576-42AF-8429-DDB2D74FF613Q37674501-091E5886-FDAC-4EE1-A69C-8B5DA92E6513Q37741774-4861E522-616D-4277-A4A0-CDD3B7F61693Q38055459-83420308-D141-47CF-B932-CF9D707C8028Q44498721-7C1EB32A-66EA-4155-8A51-84F781781A54Q46581570-32BC8903-F980-4D60-B322-042596D721AEQ46957087-4A39EE26-B14F-4D53-BD84-76292FB9D15EQ47147531-7179FE22-3924-4D9F-828A-219CB395B0A1Q47162185-262F5D56-29AF-4E6E-BFD8-DEDD7CA5490AQ48506802-E4C80A0A-A171-4DC5-B4DE-8078E970B5DA
P2860
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Occult ovarian cancers identif ...... of BRCA1/2 mutation carriers.
@ast
Occult ovarian cancers identif ...... of BRCA1/2 mutation carriers.
@en
Occult ovarian cancers identif ...... of BRCA1/2 mutation carriers.
@nl
type
label
Occult ovarian cancers identif ...... of BRCA1/2 mutation carriers.
@ast
Occult ovarian cancers identif ...... of BRCA1/2 mutation carriers.
@en
Occult ovarian cancers identif ...... of BRCA1/2 mutation carriers.
@nl
prefLabel
Occult ovarian cancers identif ...... of BRCA1/2 mutation carriers.
@ast
Occult ovarian cancers identif ...... of BRCA1/2 mutation carriers.
@en
Occult ovarian cancers identif ...... of BRCA1/2 mutation carriers.
@nl
P2093
P2860
P50
P1476
Occult ovarian cancers identif ...... of BRCA1/2 mutation carriers.
@en
P2093
Christian F Singer
Ellen Matloff
Gabriella Pichert
Gail Tomlinson
Henry T Lynch
Joanne L Blum
Judy E Garber
Mary B Daly
Nadine Tung
Patricia A Ganz
P2860
P2888
P304
P356
10.1007/S10549-010-0799-X
P407
P50
P577
2010-02-24T00:00:00Z
P5875
P6179
1033617031